SMTL ID : 4otr.1

Crystal structure of BTK kinase domain complexed with 6-cyclopropyl-2-[3-[5-[[5-(4-ethylpiperazin-1-yl)-2-pyridyl]amino]-1-methyl-6-oxo-3-pyridyl]-2-(hydroxymethyl)phenyl]-8-fluoro-isoquinolin-1-one

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 2V3: 6-cyclopropyl-2-[3-(5-{[5-(4-ethylpiperazin-1-yl)pyridin-2-yl]amino}-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-(hydroxymethyl)phenyl]-8-fluoroisoquinolin-1(2H)-one(Non-covalent)

2V3.1: 23 residues within 4Å: Chain A: K.30, L.32, G.33, T.34, G.35, Q.36, F.37, V.40, A.52, K.54, T.98, E.99, Y.100, M.101, A.102, G.104, N.150, L.152, S.162, D.163, S.167, V.170, Y.175 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.32, A:Q.36, A:F.37, A:V.40, A:V.40, A:D.163, A:V.170 Hydrogen bonds: A:K.54, A:M.101, A:M.101, A:S.162, A:S.162 Water bridges: A:G.35, A:C.105

2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 7 residues within 4Å: Chain A: R.144, S.167, Y.175, T.176, F.183, P.184, F.198 No protein-ligand interaction detected (PLIP) DMS.3: 7 residues within 4Å: Chain A: R.144, P.184, W.187, S.188, V.192, F.198, S.202 2 PLIP interactions: 2 interactions with chain A Water bridges: A:R.144, A:R.144

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lou, Y. et al., Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis. J.Med.Chem. (2015)

Release Date

2014-05-14

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence